(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RS SYNTHESIS QUALITY THROUGH PEPTIDE DESIGN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RS SYNTHESIS QUALITY THROUGH PEPTIDE DESIGN

ST13

US500000086851267

Class

1

Filing

86851267

Registration

5117422

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

01/11/2026

Trademark type

Combined

Nice classes

1

Filing date

12/16/2015

Registration date

01/10/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/15/2023

Last transaction

01/11/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

08/29/2009

First use in commerce

09/20/2009

Drawing code

3

Owner type

16

Owner location

Louisville, KY

Examiner

WATTS-FITZGERALD,CAITLIN C

Law office

M20

Current location

TMO LAW OFFICE 111

Mark description

The mark consists of a circular graphic, with the company name "RS synthesis" next to it ("RS" in upper case, "synthesis" lower case) next to it, and the phrase "Quality Through Peptide Design" below the company name in smaller font.

Holders and representatives

Holders

RS Synthesis LLC

Representatives

RS Synthesis LLC

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; biomedical compoundscustom peptides for use in the research and development of biopharmaceuticals; GMP peptide and API manufacturing for use in clinical trials; biomedical compoundscustom peptides for use in the manufacture of cosmetics; Biochemicalspolyclonal antibodies for in vitro scientific or research studies

Publications

History of USPTO decisions and trademark events.

22 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/10/2026

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

05/15/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

05/15/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/11/2023

ES8R

TEAS SECTION 8 RECEIVED

10/24/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/10/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/17/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

01/10/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/25/2016

PUBO

PUBLISHED FOR OPPOSITION

10/25/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/22/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/21/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/20/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/20/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/02/2016

GNRT

NON-FINAL ACTION E-MAILED

04/02/2016

CNRT

NON-FINAL ACTION WRITTEN

04/02/2016

DOCK

ASSIGNED TO EXAMINER

04/01/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/23/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/22/2015

NWAP

NEW APPLICATION ENTERED

12/19/2015

Continuous trademark protection

Get notified about every new filing that threatens RS SYNTHESIS QUALITY THROUGH PEPTIDE DESIGN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.